HRP20200372T1 - Postupci proizvodnje poloksamera za upotrebu u mediju za staničnu kulturu - Google Patents
Postupci proizvodnje poloksamera za upotrebu u mediju za staničnu kulturu Download PDFInfo
- Publication number
- HRP20200372T1 HRP20200372T1 HRP20200372TT HRP20200372T HRP20200372T1 HR P20200372 T1 HRP20200372 T1 HR P20200372T1 HR P20200372T T HRP20200372T T HR P20200372TT HR P20200372 T HRP20200372 T HR P20200372T HR P20200372 T1 HRP20200372 T1 HR P20200372T1
- Authority
- HR
- Croatia
- Prior art keywords
- poloxamer
- minutes
- heated
- cell
- culture medium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
- C08G65/48—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
- C08G2650/50—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type containing nitrogen, e.g. polyetheramines or Jeffamines(r)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
- C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Polyesters Or Polycarbonates (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461970281P | 2014-03-25 | 2014-03-25 | |
| EP15715932.8A EP3122799B8 (en) | 2014-03-25 | 2015-03-25 | Methods of preparing a poloxamer for use in cell culture medium |
| PCT/US2015/022592 WO2015148736A1 (en) | 2014-03-25 | 2015-03-25 | Methods of preparing a poloxamer for use in cell culture medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20200372T1 true HRP20200372T1 (hr) | 2020-06-12 |
Family
ID=52824596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20200372TT HRP20200372T1 (hr) | 2014-03-25 | 2015-03-25 | Postupci proizvodnje poloksamera za upotrebu u mediju za staničnu kulturu |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11034793B2 (enExample) |
| EP (2) | EP3778702B1 (enExample) |
| JP (3) | JP6655548B2 (enExample) |
| KR (1) | KR102352250B1 (enExample) |
| CN (2) | CN111808276A (enExample) |
| AU (1) | AU2015236008B2 (enExample) |
| BR (1) | BR112016021739B1 (enExample) |
| CA (1) | CA2943357C (enExample) |
| ES (1) | ES2778680T3 (enExample) |
| HR (1) | HRP20200372T1 (enExample) |
| IL (2) | IL247902B (enExample) |
| MX (2) | MX2016012288A (enExample) |
| MY (1) | MY178060A (enExample) |
| PL (1) | PL3122799T3 (enExample) |
| RU (1) | RU2710551C2 (enExample) |
| SG (1) | SG11201607929PA (enExample) |
| SI (1) | SI3122799T1 (enExample) |
| WO (1) | WO2015148736A1 (enExample) |
| ZA (1) | ZA201606711B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201607929PA (en) | 2014-03-25 | 2016-10-28 | Genentech Inc | Methods of preparing a poloxamer for use in cell culture medium |
| KR20180125999A (ko) | 2016-03-17 | 2018-11-26 | 메르크 파텐트 게엠베하 | 폴록사머의 정제 방법 |
| KR102544922B1 (ko) * | 2017-12-21 | 2023-06-16 | 시그마-알드리치 컴퍼니., 엘엘씨 | 폴록사머 조성물 및 이의 제조 및 사용 방법 |
| WO2020013725A1 (en) * | 2018-07-12 | 2020-01-16 | Arshintseva Elena Valentinovna | Thermal method for sterilizing poloxamer comprising liquid drugs |
| JPWO2020022511A1 (ja) * | 2018-07-27 | 2021-08-02 | 味の素株式会社 | 動物細胞の浮遊培養用の添加物、浮遊培養用培地および浮遊培養方法 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE266710C (enExample) | ||||
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| WO1990003430A1 (en) | 1988-09-23 | 1990-04-05 | Cetus Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| EP1690935A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| US5531925A (en) | 1991-10-04 | 1996-07-02 | Gs Biochem Ab | Particles, method of preparing said particles and uses thereof |
| CA2181164C (en) * | 1994-01-14 | 2008-01-08 | Arnold Horwitz | Anti-gram-positive bacterial methods and materials |
| US5912228A (en) * | 1995-01-13 | 1999-06-15 | Xoma Corporation | Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products |
| CA2219361C (en) | 1995-04-27 | 2012-02-28 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| EP1972194A1 (en) | 1996-12-03 | 2008-09-24 | Amgen Fremont Inc. | Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| GB9625175D0 (en) * | 1996-12-04 | 1997-01-22 | Medi Cult As | Serum-free cell culture media |
| US5804420A (en) | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| KR100797667B1 (ko) | 1999-10-04 | 2008-01-23 | 메디카고 인코포레이티드 | 외래 유전자의 전사를 조절하는 방법 |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| TWI367113B (en) * | 2003-02-12 | 2012-07-01 | Syncera Inc | Random and non-random alkylene oxide polymer alloy compositions |
| AU2003900887A0 (en) * | 2003-02-27 | 2003-03-13 | Novasel Australia Pty Ltd | Poloxamer emulsion preparations |
| US8802116B2 (en) * | 2003-02-27 | 2014-08-12 | Novasel Australia Pty. Ltd. | Poloxamer emulsion preparations |
| US9522377B2 (en) | 2003-08-04 | 2016-12-20 | Camurus Ab | Method for improving the properties of amphiphile particles |
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| US20060121016A1 (en) | 2004-10-18 | 2006-06-08 | Lee Raphael C | Methods and compositions for treatment of free radical injury |
| US9149433B2 (en) | 2004-11-30 | 2015-10-06 | Basf Corporation | Method for formation of micro-prilled polymers |
| CN1939534B (zh) * | 2005-09-27 | 2010-12-01 | 长春金赛药业股份有限公司 | 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂 |
| WO2008021347A2 (en) | 2006-08-16 | 2008-02-21 | Novartis Ag | Method for making solid dispersions of highly crystalline therapeutic compounds |
| KR100932613B1 (ko) | 2007-04-27 | 2009-12-17 | 한남대학교 산학협력단 | 고분자 용융공정을 이용한 약물전달용 생체적합성 고분자나노 미립구의 제조방법 및 그 나노 미립구 |
| WO2009055312A1 (en) * | 2007-10-22 | 2009-04-30 | Dfb Pharmaceuticals, Inc. | Process for producing a poloxamer gel |
| SI2574677T1 (sl) * | 2007-12-27 | 2017-11-30 | Baxalta GmbH | Procesi celične kulture |
| WO2011077035A1 (fr) * | 2009-12-23 | 2011-06-30 | Sanofi Pasteur | Procede de culture de cellules adherentes |
| US9629811B2 (en) * | 2012-03-30 | 2017-04-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Microsphere compositions, preparation method and applications thereof |
| SG11201607929PA (en) * | 2014-03-25 | 2016-10-28 | Genentech Inc | Methods of preparing a poloxamer for use in cell culture medium |
-
2015
- 2015-03-25 SG SG11201607929PA patent/SG11201607929PA/en unknown
- 2015-03-25 BR BR112016021739-0A patent/BR112016021739B1/pt active IP Right Grant
- 2015-03-25 CN CN202010723304.6A patent/CN111808276A/zh active Pending
- 2015-03-25 MY MYPI2016001715A patent/MY178060A/en unknown
- 2015-03-25 EP EP20151556.6A patent/EP3778702B1/en active Active
- 2015-03-25 HR HRP20200372TT patent/HRP20200372T1/hr unknown
- 2015-03-25 EP EP15715932.8A patent/EP3122799B8/en active Active
- 2015-03-25 KR KR1020167029244A patent/KR102352250B1/ko active Active
- 2015-03-25 SI SI201531128T patent/SI3122799T1/sl unknown
- 2015-03-25 JP JP2016558605A patent/JP6655548B2/ja active Active
- 2015-03-25 CN CN201580026701.5A patent/CN106414552B/zh active Active
- 2015-03-25 ES ES15715932T patent/ES2778680T3/es active Active
- 2015-03-25 MX MX2016012288A patent/MX2016012288A/es unknown
- 2015-03-25 AU AU2015236008A patent/AU2015236008B2/en active Active
- 2015-03-25 RU RU2016141568A patent/RU2710551C2/ru active
- 2015-03-25 CA CA2943357A patent/CA2943357C/en active Active
- 2015-03-25 WO PCT/US2015/022592 patent/WO2015148736A1/en not_active Ceased
- 2015-03-25 PL PL15715932T patent/PL3122799T3/pl unknown
-
2016
- 2016-09-19 IL IL247902A patent/IL247902B/en active IP Right Grant
- 2016-09-22 US US15/273,155 patent/US11034793B2/en active Active
- 2016-09-22 MX MX2021001981A patent/MX2021001981A/es unknown
- 2016-09-28 ZA ZA2016/06711A patent/ZA201606711B/en unknown
-
2020
- 2020-02-04 JP JP2020017136A patent/JP2020103290A/ja not_active Withdrawn
- 2020-12-20 IL IL279583A patent/IL279583B/en unknown
-
2021
- 2021-05-13 US US17/319,886 patent/US11912823B2/en active Active
-
2022
- 2022-09-30 JP JP2022157928A patent/JP7472222B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ761568A (en) | Anti-cd47 antibodies and uses thereof | |
| MX2016017017A (es) | Proceso para la preparacion de una poliamida semi-aromatica, semi-cristalina. | |
| JP2016536391A5 (enExample) | ||
| EP2863426A4 (en) | HEAT INTERFACE FILM, MANUFACTURING METHOD AND COOLING SYSTEM THEREFOR | |
| CO2018005265A2 (es) | Vacunas de ácido nucleico para el virus varicela-zóster | |
| Sommer et al. | Ultra-high temperature granulite-facies metamorphic rocks from the Mozambique belt of SW Tanzania | |
| RU2010105488A (ru) | Способ стерилизации компота из черешни | |
| JP2017516459A5 (enExample) | ||
| BR112016030326A2 (pt) | ?poliepítopo quimérico, polinucleotídeo, vetores, célula, partículas de vírus, composição imunogênica, método para prevenir e/ou tratar infecções e método de produção de partículas de mv? | |
| BR112014031126A2 (pt) | processo de tratamento térmico de pós | |
| EP3510058A4 (en) | Polymerizing composition, method of manufacture thereof and articles comprising the same | |
| MX374489B (es) | Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas, y método de preparación de la misma. | |
| SG195199A1 (en) | Untitled | |
| HK1218866A1 (zh) | 基於b细胞谱系的人源化动物的免疫原设计 | |
| RU2016141568A (ru) | Способы приготовления полоксамера для применения в клеточной культуральной среде | |
| MX2017000136A (es) | Metodo para revestir material de aleta de aluminio con pelicula hidrofilica, material de aleta de aluminio, e intercambiador de calor de aluminio. | |
| MY185543A (en) | Polymer composition, its method of preparation, its use and composition comprising it | |
| RU2017109663A (ru) | Цементная композиция и способ получения отвержденного цементного изделия с использованием этой композиции | |
| EP2806454A4 (en) | SEMICONDUCTOR COMPOSITION COMPOSITION, SEMICONDUCTOR COMPONENT AND MANUFACTURING METHOD THEREFOR, AND POLYMER AND METHOD OF MANUFACTURING THEREOF | |
| EP3022297C0 (en) | Genetically stable oncolytic rna virus, method of manufacturing and use thereof | |
| WO2015191195A8 (en) | Propylene-based polymers having improved stability and methods for producing the same | |
| WO2016141320A3 (en) | Non-neuroinvasive viruses and uses thereof | |
| MY153875A (en) | A method of producing a polytetrafluoroethylene adhesive polymer membrane | |
| AR106031A1 (es) | Geles poliméricos, método de preparación y usos de los mismos | |
| BR112015021772A2 (pt) | método para a preparação de células embrionárias aviárias, método melhorado para a preparação de células embrionárias aviárias a partir de um embrião, cultura ou composição de células embrionárias aviárias, método para a produção ou amplificação de um vírus, e, composição de vacina |